Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Heinzer

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Urologic Oncology|November 3, 2009
Prostate cancer in the elderlyHans Heinzer, Thomas Steuber
Current Opinion in Urology|October 16, 2003
Renal cell carcinoma: novel treatments for advanced diseaseEdith Huland, Hans Heinzer
Current Opinion in Urology|June 19, 2004
Renal cell carcinoma - innovative medical treatmentsEdith Huland, Hans Heinzer
Onkologie|September 25, 2007
Managing side effects of angiogenesis inhibitors in renal cell carcinomaViktor Grünwald, Hans Heinzer, Walter Fiedler
Urologie (Heidelberg, Germany)|September 13, 2023
[Role of nutrition in urological prehabilitation]Imke Thederan, Birgit-Christiane Zyriax, Hans Heinzer
World Journal of Urology|March 5, 2019
External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomySophie Knipper, David Pröwrock, Zhe Tian, et al.
The Journal of Urology|June 7, 2006
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomyUwe H G Michl, Martin G Friedrich, Markus Graefen, et al.
European Urology|August 12, 2008
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysisChristian Eichelberg, Roman Heuer, Felix K Chun, et al.
Urologic Oncology|January 23, 2016
Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancerChristian P Meyer, Klaus Pantel, Pierre Tennstedt, et al.
European Urology|April 5, 2011
Full functional-length urethral sphincter preservation during radical prostatectomyThorsten Schlomm, Hans Heinzer, Thomas Steuber, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Urologic Oncology|November 3, 2009
Prostate cancer in the elderlyHans Heinzer, Thomas Steuber
Current Opinion in Urology|October 16, 2003
Renal cell carcinoma: novel treatments for advanced diseaseEdith Huland, Hans Heinzer
Current Opinion in Urology|June 19, 2004
Renal cell carcinoma - innovative medical treatmentsEdith Huland, Hans Heinzer
Onkologie|September 25, 2007
Managing side effects of angiogenesis inhibitors in renal cell carcinomaViktor Grünwald, Hans Heinzer, Walter Fiedler
Urologie (Heidelberg, Germany)|September 13, 2023
[Role of nutrition in urological prehabilitation]Imke Thederan, Birgit-Christiane Zyriax, Hans Heinzer
World Journal of Urology|March 5, 2019
External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomySophie Knipper, David Pröwrock, Zhe Tian, et al.
The Journal of Urology|June 7, 2006
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomyUwe H G Michl, Martin G Friedrich, Markus Graefen, et al.
European Urology|August 12, 2008
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysisChristian Eichelberg, Roman Heuer, Felix K Chun, et al.
Urologic Oncology|January 23, 2016
Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancerChristian P Meyer, Klaus Pantel, Pierre Tennstedt, et al.
European Urology|April 5, 2011
Full functional-length urethral sphincter preservation during radical prostatectomyThorsten Schlomm, Hans Heinzer, Thomas Steuber, et al.
Pageof 15